PMID: 6105342Jul 26, 1980Paper

Propranolol--a medical treatment for portal hypertension?

Lancet
D LebrecJ P Benhamou

Abstract

Continuous, oral administration of propranolol at doses which reduced the heart-rate by 25% produced a sustained decrease in portal venous pressure in cirrhotic patients with portal hypertension. This effect of propranolol might be useful in preventing recurrent bleeding due to ruptured oesophageal varices in patients with portal hypertension.

References

Mar 1, 1968·Circulation·E D FrohlichI H Page
Oct 1, 1961·Circulation·S SHALDONS SHERLOCK

❮ Previous
Next ❯

Citations

Jan 1, 1987·European Journal of Clinical Pharmacology·P E HallM J Kendall
Jan 1, 1984·European Journal of Clinical Pharmacology·K TöttermanF Fyhrquist
Jul 1, 1983·Digestive Diseases and Sciences·T PoynardJ C Chaput
Feb 1, 1986·Digestive Diseases and Sciences·H SankaryG R Mason
Mar 1, 1988·Digestive Diseases and Sciences·L PagliaroF Tinè
Oct 15, 1982·Klinische Wochenschrift·G H BützowA Bräuer
Sep 1, 1991·Baillière's Clinical Gastroenterology·J D Rose, P M Smith
Sep 1, 1992·Baillière's Clinical Gastroenterology·G Spina, R Santambrogio
Mar 12, 1999·The Surgical Clinics of North America·H E VargasK Abu-Elmagd
Aug 15, 1981·Lancet·A S Evans, G W Comstock
Nov 6, 1982·Lancet·J M SteelC M Gosden
Oct 30, 1982·Lancet·H R van BuurenJ Silberbusch
Feb 20, 2003·Journal of Hepatology·Jaime BoschRoberto Groszmann
Aug 29, 1998·Journal of Hepatology·J H HenriksenN J Christensen
Aug 26, 1999·Ultrasound in Medicine & Biology·F PiscagliaL Bolondi
Dec 19, 2000·European Journal of Ultrasound : Official Journal of the European Federation of Societies for Ultrasound in Medicine and Biology·S KapicioğluC Tuncer
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T D Boyer
Jun 24, 1982·The New England Journal of Medicine
Aug 26, 1982·The New England Journal of Medicine·D LebrecJ P Benhamou
Mar 20, 1986·The New England Journal of Medicine
Jul 1, 1993·Journal of Gastroenterology and Hepatology·G H LoK J Lo
Oct 1, 1995·Australian and New Zealand Journal of Medicine·N L Sandford, P Kerlin
Jan 26, 2005·Internal Medicine Journal·J S Lubel, P W Angus
Jun 1, 1996·Alcoholism, Clinical and Experimental Research·M K Bay, S Schenker
Dec 1, 1981·Archives of Disease in Childhood·I A LaingM S Fraser
Aug 27, 1983·British Medical Journal·D TarverS Sherlock
Sep 10, 1983·British Medical Journal·P C HayesI A Bouchier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.